Search

The PbO2/Co3O4composite electrodes were synthesized using the composite co-deposition method, which involved the incorporation of Co3O4nanoparticles into a PbO2coating. These composite electrodes were employed as anodes for phenol electrooxidation in wastewater treatment. The results demonstrate that the PbO2/Co3O4composite electrode exhibits a three-dimensional porous structure, leading to a significant increase in the electrochemically active surface area. Electrochemical measurements indicate that the composite electrode achieves a minimum oxygen evolution potential of 526.5 mV. Moreover, the electrode facilitates the indirect degradation of phenol, even at low voltage (0.45 V). The unique structure, improved conductivity, and enhanced surface area of the electrode contribute to its exceptional performance in phenol degradation. Additionally, this approach offers the potential for synergistic integration with other treatment methods, providing a sustainable and energy-efficient solution for removing persistent organic compounds from wastewater.

Among the >120 modified ribonucleosides in the prokaryotic epitranscriptome, many tRNA modifications are critical to bacterial survival, which makes their synthetic enzymes ideal targets for antibiotic development. Here we performed a structure-based design of inhibitors of tRNA-(N1G37) methyltransferase, TrmD, which is an essential enzyme in many bacterial pathogens. On the basis of crystal structures of TrmDs from Pseudomonas aeruginosaand Mycobacterium tuberculosis, we synthesized a series of thienopyrimidinone derivatives with nanomolar potency against TrmD in vitro and discovered a novel active site conformational change triggered by inhibitor binding. This tyrosine-flipping mechanism is uniquely found in P. aeruginosaTrmD and renders the enzyme inaccessible to the cofactor S-adenosyl-l-methionine (SAM) and probably to the substrate tRNA. Biophysical and biochemical structure–activity relationship studies provided insights into the mechanisms underlying the potency of thienopyrimidinones as TrmD inhibitors, with several derivatives found to be active against Gram-positive and mycobacterial pathogens. These results lay a foundation for further development of TrmD inhibitors as antimicrobial agents.